About this document

MRD Testing in Acute Lymphoblastic Leukemia by JAIR_valencia3395 is a document available to read on EtoBox.

1. Minimal residual disease (MRD) assays are increasingly used to evaluate treatment response in acute lymphoblastic leukemia (ALL) patients. MRD assays can detect one ALL cell among 10,000 to 100,000 normal cells. 2. The clinical significance of MRD has been shown in both childhood and adult ALL. Higher MRD levels during or after induction therapy generally correlate with higher risk of relapse. 3. MRD is now used in clinical trials to assign risk level and guide treatment intensification. The time poi

Author

JAIR_valencia3395

Language

EN